Base inhibitors

Trending/Base inhibitors

Alzheimer disease, neuron network with amyloid plaques

Alzheimer’s disease drug fails in trial

Merck is halting a trial of verubecestat, an Alzheimer's disease medication. The pharmaceuticals company concluded the drug has “virtually no chance of finding a positive clinical effect.”…

No information found.

Sign up